The IPI Model: Breaking Down CMS's Proposed Drug Pricing Model | McDermott Skip to main content

The IPI Model: Breaking Down CMS’s Proposed Drug Pricing Model

The IPI Model: Breaking Down CMS’s Proposed Drug Pricing Model

Überblick


Join McDermott for a Webinar on Changes to the Pharma Ecosystem

The Centers for Medicare and Medicaid Services (CMS)’s October 25 announcement of an Advanced Notice of Proposed Rulemaking with Comment proposes to implement an international pricing index model for Medicare Part B drugs and biologicals. This model has the potential to make sweeping changes to the entire pharmaceutical ecosystem.

Join McDermott Will & Emery’s Emily Cook and McDermott+Consulting’s John Warren as they lead a discussion on the impact of CMS’s proposed model and break down the implications on stakeholder groups from providers to drug manufacturers.

Click here to register.

For more information, please contact Jennifer Randles.

Mehr erfahren

New York, NY / In-person / October 16, 2025

HPE NYC 2025

Paris, France / Event Sponsoring / October 7-8, 2025

HTID | Healthtech Innovation Days 2025

Chicago, IL / In-person / September 18, 2025

Chicago Boot Camp for Private Equity Professionals 2025

New York, NY / In-person / September 17, 2025

New York Boot Camp for Private Equity Professionals 2025

San Diego, California / In-person / July 1, 2025

AHLA Annual Meeting Reception 2025